OREGON PUBLIC EMPLOYEES RETIREMENT FUND - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
OREGON PUBLIC EMPLOYEES RETIREMENT FUND ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,274,007
+2.3%
14,222
-2.7%
0.02%
+20.0%
Q2 2023$1,244,917
+2.2%
14,622
-0.7%
0.02%0.0%
Q1 2023$1,218,246
+4.0%
14,722
-1.2%
0.02%0.0%
Q4 2022$1,171,649
+5.6%
14,897
-0.6%
0.02%
-6.2%
Q3 2022$1,109,000
+14.2%
14,986
+0.6%
0.02%
+6.7%
Q2 2022$971,000
-6.4%
14,897
-9.1%
0.02%
+36.4%
Q1 2022$1,037,000
+18.0%
16,397
-1.1%
0.01%
+10.0%
Q4 2021$879,000
-27.1%
16,581
-2.9%
0.01%
-28.6%
Q3 2021$1,206,000
+4.6%
17,081
-1.3%
0.01%
+7.7%
Q2 2021$1,153,000
-38.5%
17,306
+2.5%
0.01%
-40.9%
Q1 2021$1,874,000
-5.9%
16,878
+0.7%
0.02%
-15.4%
Q4 2020$1,991,000
+33.4%
16,768
-2.0%
0.03%
+18.2%
Q3 2020$1,492,000
-11.8%
17,106
-9.5%
0.02%
-12.0%
Q2 2020$1,692,000
-11.1%
18,894
-1.1%
0.02%
-24.2%
Q1 2020$1,904,000
-13.9%
19,103
-0.7%
0.03%
+6.5%
Q4 2019$2,211,000
-16.6%
19,243
-8.5%
0.03%
-11.4%
Q3 2019$2,652,000
+6.8%
21,028
+2.0%
0.04%
+2.9%
Q2 2019$2,482,000
+37.8%
20,623
+0.2%
0.03%
+30.8%
Q1 2019$1,801,000
-12.6%
20,5890.0%0.03%
-21.2%
Q4 2018$2,060,000
+32.7%
20,589
+52.0%
0.03%
+57.1%
Q3 2018$1,552,000
+5869.2%
13,548
+4571.7%
0.02%
Q2 2018$26,0002900.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders